Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

12.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.8K
6.8K
Neural Regulation01:37

Neural Regulation

43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Dysfunction and Cognitive Decline: A Review of Nutritional and Brain Structural Pathways Linking Tooth Loss, Oral Frailty, and Solitary Eating to Dementia.

Nutrients·2026
Same author

Serum Albumin Levels Are Associated with Total Brain and Hippocampal Volume but Not with White Matter Lesion Volume in Older Japanese Adults Without Cognitive Decline: A Cross-Sectional Study.

Nutrients·2026
Same author

Successful Amyloid Removal by Donanemab Treatment in a Female Patient With Alzheimer Disease: A Case Report.

Neurology·2026
Same author

Gadolinium enhancement of the cauda equina in a case of familial ALS with p.S135G <i>SOD1</i> mutation.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD).

Journal of Alzheimer's disease reports·2026
Same author

Solitary eating is linked to reduced brain volume in cognitively unimpaired individuals and possible future cognitive decline.

npj aging·2025

Related Experiment Video

Updated: Feb 24, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K

The Oligomer Hypothesis in α-Synucleinopathy.

Kenjiro Ono1

  • 1Department of Neurology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan. onoken@med.showa-u.ac.jp.

Neurochemical Research
|August 23, 2017
PubMed
Summary

Oligomers, not Lewy bodies, are key in Parkinson's disease (PD) and related disorders. This review explores the "oligomer hypothesis" for developing new treatments for these neurodegenerative diseases.

Keywords:
Oligomer hypothesisOligomersParkinson’s diseaseα-Synucleinα-Synucleinopathy

More Related Videos

Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.4K
Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.1K

Related Experiment Videos

Last Updated: Feb 24, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.2K
Studying Pre-formed Fibril Induced &#945;-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.4K
Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.1K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Parkinson's disease (PD) and dementia with Lewy bodies are characterized by Lewy bodies and neurites.
  • These pathological hallmarks contain amyloid-like fibrils of alpha-synuclein (αS).
  • αS aggregation is a critical factor in the development of synucleinopathies.

Purpose of the Study:

  • To review recent findings supporting the "oligomer hypothesis" in synucleinopathy research.
  • To highlight the central role of αS oligomers in the pathogenesis of PD and related diseases.

Main Methods:

  • Analysis of synthetic αS peptides.
  • Studies using cell culture models.
  • Research involving transgenic mouse models.
  • Examination of human samples (cerebrospinal fluid, blood) from PD patients.

Main Results:

  • Evidence suggests pre-fibrillar αS oligomers are more critical than fibrillar forms in disease development.
  • Oligomers are implicated as the primary pathogenic species in synucleinopathies.
  • Accumulating data supports the central role of oligomers in PD pathogenesis.

Conclusions:

  • The "oligomer hypothesis" provides a crucial framework for understanding synucleinopathies.
  • Targeting αS oligomers represents a promising therapeutic strategy for PD and related disorders.
  • Further research into αS oligomer formation and toxicity is essential for disease modification.